Tobacco Dependence Medications

150mg

designed to aid in smoking cessation and to alleviate nicotine withdrawal symptoms.

150mg

Indicated to support smoking cessation, developed to help manage nicotine withdrawal and mitigate cravings in patients treated for nicotine dependence.

0.5 · 1mg

Developed to target nicotine addiction pathways, utilized to support patients to mitigate withdrawal symptoms and cravings while quitting smoking.

150 · 300mg

Indicated to assist in managing major depression and smoking cessation, this treatment is intended to address imbalances in brain chemicals to support lasting recovery.

150mg

Indicated to address nicotine dependence, intended to mitigate withdrawal symptoms and support cessation efforts.